Peter Donhauser's most recent trade in Anavex Life Sciences Corporation was a trade of 50,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anavex Life Sciences Corp | Peter Donhauser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Anavex Life Sciences Corp | Peter Donhauser | Director | Purchase of securities on an exchange or from another person at price $ 3.64 per share. | 14 Jun 2024 | 2,835 | 5,000 (0%) | 0% | 3.6 | 10,319 | Common Stock |
| Anavex Life Sciences Corp | Peter Donhauser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Anavex Life Sciences Corp | Peter Donhauser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Anavex Life Sciences Corp | Peter Donhauser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) |